Anebulo Pharmaceuticals's total assets for Q3 2024 were $6.00M, a decrease of -20.07% from the previous quarter. ANEB total liabilities were $1.01M for the fiscal quarter, a -0.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.